💨 Abstract

CorMedix Inc. reported second-quarter profit of $19.8 million, exceeding Wall Street's expectations. The company posted revenue of $39.7 million for the period. The New Jersey-based pharmaceutical and medical device company reported earnings of 28 cents per share, surpassing the average estimate of 20 cents per share predicted by analysts.

Courtesy: WTOP Staff